195 related articles for article (PubMed ID: 35603624)
1. Clinical Efficacy of Soluble Thrombomodulin, Tissue Plasminogen Activator Inhibitor complex, Thrombin-Antithrombin complex,α2-Plasmininhibitor-Plasmin complex in Pediatric Sepsis.
Li J; Zhou J; Ren H; Teng T; Li B; Wang Y; Xiang L
Clin Appl Thromb Hemost; 2022; 28():10760296221102929. PubMed ID: 35603624
[TBL] [Abstract][Full Text] [Related]
2. Identification of soluble thrombomodulin and tissue plasminogen activator-inhibitor complex as biomarkers for prognosis and early evaluation of septic shock and sepsis-induced disseminated intravascular coagulation.
Zhang J; Xue M; Chen Y; Liu C; Kuang Z; Mu S; Wei W; Yin J; Xiang H; Hu Y; Long X; Fang S; Sun S; Wang B; Tong C; Song Z
Ann Palliat Med; 2021 Oct; 10(10):10170-10184. PubMed ID: 34551574
[TBL] [Abstract][Full Text] [Related]
3. Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study.
Mei H; Jiang Y; Luo L; Huang R; Su L; Hou M; Wang X; Deng J; Hu Y
Thromb Res; 2019 Jan; 173():20-26. PubMed ID: 30458338
[TBL] [Abstract][Full Text] [Related]
4. [Clinical value of new coagulation biomarkers in pediatric sepsis].
Xiang L; Li JZ; Zhou JY; Ren H; Teng T; Wang Y; Hu XW
Zhonghua Er Ke Za Zhi; 2023 Mar; 61(3):222-227. PubMed ID: 36849348
[No Abstract] [Full Text] [Related]
5. Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study.
Koyama K; Madoiwa S; Nunomiya S; Koinuma T; Wada M; Sakata A; Ohmori T; Mimuro J; Sakata Y
Crit Care; 2014 Jan; 18(1):R13. PubMed ID: 24410881
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.
Zhou K; Zhang J; Zheng ZR; Zhou YZ; Zhou X; Wang LD; Suo B; Jiang XF; Liu PJ; Wang DH
Clin Appl Thromb Hemost; 2020; 26():1076029620971041. PubMed ID: 33141604
[TBL] [Abstract][Full Text] [Related]
7. Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin.
Katayama S; Nunomiya S; Koyama K; Wada M; Koinuma T; Goto Y; Tonai K; Shima J
Crit Care; 2017 Aug; 21(1):229. PubMed ID: 28841902
[TBL] [Abstract][Full Text] [Related]
8. Thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasmin-α2-plasmininhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective comparative cohort study.
Wang L; Zhong J; Xiao D; Huang W; Zheng Z; Jiang Y
Ann Transl Med; 2022 Dec; 10(23):1273. PubMed ID: 36618792
[TBL] [Abstract][Full Text] [Related]
9. Performance evaluation of thrombomodulin, thrombin-antithrombin complex, plasmin-α2-antiplasmin complex, and t-PA: PAI-1 complex.
Chen Q; Shou W; Wu W; Wang G; Cui W
J Clin Lab Anal; 2019 Jul; 33(6):e22913. PubMed ID: 31090232
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of TAT, PIC and t-PAIC as predictive markers for severe sepsis in pediatric patients.
Bai H; Shen L; Zhang H; Tang N
Front Pediatr; 2024; 12():1336583. PubMed ID: 38562140
[TBL] [Abstract][Full Text] [Related]
11. The clinical significance of TAT, PIC, TM, and t-PAIC in vascular events of BCR/ABL-negative myeloproliferative neoplasms.
Huang K; Mo Q; Liao C; Feng S; Liu G; Jiang D; Lei P
Clin Exp Med; 2024 May; 24(1):107. PubMed ID: 38776019
[TBL] [Abstract][Full Text] [Related]
12. Alterations in coagulation and fibrinolysis during sepsis.
Kidokoro A; Iba T; Fukunaga M; Yagi Y
Shock; 1996 Mar; 5(3):223-8. PubMed ID: 8696988
[TBL] [Abstract][Full Text] [Related]
13. Potential Biomarkers for Early Diagnosis, Evaluation, and Prognosis of Sepsis-Induced Coagulopathy.
Li Y; Li H; Wang Y; Guo J; Zhang D
Clin Appl Thromb Hemost; 2023; 29():10760296231195089. PubMed ID: 37605466
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
Watanabe R; Wada H; Miura Y; Murata Y; Watanabe Y; Sakakura M; Okugawa Y; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Shiku H; Nobori T
Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985
[TBL] [Abstract][Full Text] [Related]
15. The values of coagulation function in COVID-19 patients.
Jin X; Duan Y; Bao T; Gu J; Chen Y; Li Y; Mao S; Chen Y; Xie W
PLoS One; 2020; 15(10):e0241329. PubMed ID: 33119703
[TBL] [Abstract][Full Text] [Related]
16. Trimester-specific reference intervals of TAT, TM, tPAI-C and PIC for healthy Chinese pregnant women.
Wu Y; Qiao Y; Zhang Y; Li Q; Zhang W
J Obstet Gynaecol Res; 2021 Jan; 47(1):368-374. PubMed ID: 33345424
[TBL] [Abstract][Full Text] [Related]
17. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
18. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
Soeki T; Tamura Y; Fukuda N; Ito S
Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
[TBL] [Abstract][Full Text] [Related]
19. Coagulation and Fibrinolysis Biomarkers as Potential Indicators for the Diagnosis and Classification of Ovarian Hyperstimulation Syndrome.
Li S; Qian Y; Pei Y; Wu K; Lu S
Front Med (Lausanne); 2021; 8():720342. PubMed ID: 34513881
[No Abstract] [Full Text] [Related]
20. Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation.
Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi K; Shirakawa S; Hayashi T
Am J Hematol; 1993 Oct; 44(2):85-8. PubMed ID: 8266924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]